BVXV — Biondvax Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapMomentum Trap
- $23.28m
- $30.14m
Annual cashflow statement for Biondvax Pharmaceuticals, fiscal year end - December 31st, ILS millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.6 | -87.7 | -109 | -4.46 | -40 |
| Depreciation | |||||
| Non-Cash Items | 21.7 | 12.3 | 33.8 | -55.9 | 23.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.34 | 17.9 | -3.35 | -14.6 | -10.9 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.1 | -57.2 | -77.1 | -72.5 | -24.5 |
| Capital Expenditures | -4.51 | -23.7 | -7.43 | -6.13 | -0.43 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 11.3 | 0.277 | 0.23 | 0.197 | 0.069 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.76 | -23.5 | -7.2 | -5.93 | -0.361 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 61.8 | 84.3 | 85.2 | 13.7 | 67.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 55.7 | 4.5 | -3.42 | -63 | 44.6 |